China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
Rank in Stocks
#2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Share Price
$3.74
Market Cap
$6.23B
Change (1 day)
-2.11%
Change (1 year)
-8.54%
Country
CN
Trade China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Category
Healthcare
Earnings for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Earnings in Jun 2026 TTM: $714.70M
According to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. latest financial reports the company's current earnings are $714.70M. In 2024 the company made an earning of $629.34M, an increase over its 2023 earnings that were of $530.39M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. from 2001 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $714.70M | 2.80% |
| 2025 | $695.23M | 10.47% |
| 2024 | $629.34M | 18.65% |
| 2023 | $530.39M | 37.94% |
| 2022 | $384.52M | 21.98% |
| 2020 | $315.25M | -14.08% |
| 2019 | $366.92M | 46.83% |
| 2018 | $249.89M | 7.08% |
| 2017 | $233.36M | 11.49% |
| 2016 | $209.31M | -11.11% |
| 2015 | $235.46M | 15.78% |
| 2014 | $203.36M | -9.34% |
| 2013 | $224.32M | 8.45% |
| 2012 | $206.84M | 37.53% |
| 2011 | $150.40M | -4.00% |
| 2010 | $156.66M | 18.25% |
| 2009 | $132.48M | 39.94% |
| 2008 | $94.67M | 79.81% |
| 2007 | $52.65M | 60.01% |
| 2006 | $32.90M | 52.20% |
| 2005 | $21.62M | -126.33% |
| 2004 | $-82.11M | -349.03% |
| 2003 | $32.97M | 44.24% |
| 2002 | $22.86M | 11.09% |
| 2001 | $20.58M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $3.62B | 406.21% |
DE
|
|
| $3.40B | 376.42% |
DE
|
|
| $1.72B | 141.17% |
JP
|
|
| $930.30M | 30.17% |
CH
|
|
| $1.69B | 136.83% |
IN
|
